Why Calif.'s Bid to Kill Berkeley's Genetic-Testing Program May Benefit Clinical Labs

If there's one thing Berkeley cherishes it's a cathartic skirmish with governments. But one may be avoided here: Even if the bill becomes law, "it will likely be too late to halt" the program. The bill could also give a boost to clinical labs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.